Anbio Biotechnology (NASDAQ:NNNN) Shares Up 7.8% – Here’s What Happened

Shares of Anbio Biotechnology (NASDAQ:NNNN) were up 7.8% on Wednesday . The company traded as high as $5.89 and last traded at $6.0160. 79,806 shares traded hands during trading, an increase of 3% from the average daily volume of 77,437 shares. The stock had previously closed at $5.58.

Analysts Set New Price Targets

Separately, Weiss Ratings cut Anbio Biotechnology from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Wednesday, July 29th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, Anbio Biotechnology presently has a consensus rating of “Sell”.

Anbio Biotechnology Trading Up 10.5%

The company has a 50-day moving average of $8.27 and a 200-day moving average of $17.78.

Anbio Biotechnology Company Profile

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.